Table 3 List of the deregulated miRNAs in the body fluids of CC compared to the healthy individuals
From: The role and diagnostic value of deregulated miRNAs in cervical cancer
miRNAs | Body fluid | Methods | Up/Down-Regulated in CC a | References |
|---|---|---|---|---|
miR‑125a‑5p | Plasma and exosomes | RNA-seq and qPCR | Down: CC < Normal | [143] |
let-7 d-3p and miR-30 d-5p | Plasma and exosomes | RNA-seq and qPCR | Down: CIN I > CIN II+ | [144] |
miR-1468-5p | Serum and exosomes | qPCR | Up: CC > Normal | [145] |
a miR‑483‑5p, miR‑1246, miR‑1275 and miR‑1290 | Serum | Array and qPCR | - Up: CC > Normal - miR-1290: CC > CIN > Normal | [146] |
miR-20a and miR-203 | Serum | qPCR | Up: CC > Normal UP: LNM (miR-20a) Down: LNM (miR-203) | [147] |
miR-150 | Serum | qPCR | Up: CC > Normal | [148] |
miR-205 | Serum | qPCR | Up: CC > Normal | [149] |
miR-9, miR-10a, miR-20a and miR-196a | Serum | qPCR | Up: CIN > Normal Up: CIN-HPV+ > CIN-HPV− | [150] |
miR-3142 | Serum | qPCR | Up: Stage-II/III > Stage-I CC | [151] |
miR-18a | Serum | qPCR | Up: Stage-III > Stage-I/II CC | [152] |
miR-221 | Serum | qPCR | Up: CC > Normal | [153] |
miR-9, miR-192 and miR-205 | Serum | qPCR | Up: CC > Precancer > Normal | [154] |
miR-766-5p | Serum | qPCR | Up: CC > Normal | [155] |
miR-152 | Serum | qPCR | Up: CC > CIN (I/II) > CIN (III/IV) > normal | [156] |
miR-21, −29a, −25, −200a and −486-5p | Serum | RNA-seq and qPCR | Up: CC > Normal | [157] |
miR-1266 | Serum | qPCR | Up: CC > HSIL > LSIL > Normal | [158] |
miR-425-5p | Serum | qPCR | Up: CC > Benign CC > Normal | [159] |
miR-G-1 | Serum | qPCR | Up: CC > Normal | [63] |
miR-497, miR-16–2* | Serum | qPCR | Up: CC > CIN and Normal | [160] |
miR-34a and miR-218 | Serum | qPCR | Up: LSIL > Normal | [161] |
miR-29a, miR-25, and miR-486-5p | Serum | qPCR | Up: early-stage (I and II) | [43] |
b miR-20a, miR-205, miR-21, miR-29a, miR-200a, miR-25, and miR-486-5p vs miR-218 | Serum | Machine learning | Up vs Down: early-stage (I and II) | [43] |
miR-15b vs miR-34a and miR-218 | Serum | qPCR | Up vs Down: (SCC vs Normal) | [161] |
miR-21 vs 125b/miR-370 | Serum | qPCR | Up vs Down: Normal and CIN compared to the early stage of CC | [162] |
miR-17-5p/miR-32-5p/miR-454-3p vs miR-409-3p | Serum | RNA-seq and qPCR | Up vs Down: (CC vs Normal) | [163] |
miR-21 vs miR-124 | Serum | qPCR | Up vs Down: (CC vs Normal) | [164] |
miR-21/miR-199a/miR-155-5p vs miR-34a/miR-145/miR-218 | Serum and Urine | qPCR | Up vs Down: (CC vs Pre-cancer and Normal) | [98] |
miR-100 | Serum | qPCR | Down: (Normal and CIN > CC) | [165] |
miR-195, miR-2861 | Serum | qPCR | Down: CC < CIN and Normal | [160] |
miR-1254 | Serum | qPCR | Down: CC < Normal | [166] |
miR-378a-3p | Serum | qPCR | Down: CC < Normal | [167] |
miR-144-3p and miR-337- 3p | Serum | qPCR | Down: CC < Normal | [168] |
miR-139-5p | Serum | qPCR | Down: CC < Normal | [169] |
miR-375-3p | Serum | qPCR | Down: CC < Normal | [170] |
miR-638, miR-521 and miR-203a-3p | Serum | qPCR | Down: Normal > CIN > CSCC | [171] |
miR-1914-5p | Serum | qPCR | Down: CIN > CSCC | [171] |
miR-29b | Serum | qPCR | Down: CC < Normal | [172] |
miR-758 | Serum | qPCR | Down: CC < Normal | [173] |
miR-378a-3p | Serum | qPCR | Down: CC < Normal | [167] |
miR-146a-5p, miR-151a-3p, miR-2110 and miR-21-5p | Plasma | qPCR | Up: CC > Normal | [174] |
miR-432 | Cervical mucus | qPCR | Down: Normal > CINII and CIN III > CC | [175] |
miR-126-3p, −20b-5p, −451a, and −144-3p | Cervical mucus | Array and qPCR | Up: SCC and AD > Normal | [176] |
miR-26b-5p, miR-142-3p, miR-143-3p, miR-191-5p, miR-223-3p and miR-338-3p | Cervical mucus | qPCR | Up: CIN3 > Normal | [177] |
miR-92a-5p and miR-155-5p | Pap smear | qPCR | Up: LSIL and HSIL > Normal | [178] |